Clinical Trials Market Size, Share, Growth Report 2032
Clinical Trials Market By Phase (Phase I, Phase II, Phase III, Phase IV) By Study Design (Observational, Interventional, Expanded Access) By Indication (Gastrointestinal, Cardiovascular, Autoimmune/Inflammation, Pain Management, CNS Condition, Cancer, Mental Disorders, Oncology, Diabetes, Obesity, Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 - 2030
Category: Healthcare Report Format : PDF
Pages: 215 Report Code: ZMR-5794
Published Date: Apr-2023 Status : Published
| Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 53.92 Billion | USD 85.01 Billion | 5.93% | 2022 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Clinical Trials Market, (2023 - 2030) (USD Billion)
- 2.2 Global Clinical Trials Market : snapshot
- Chapter 3. Global Clinical Trials Market - Industry Analysis
- 3.1 Clinical Trials Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increase in the prevalence of chronic diseases and surge in demand for personalized medicine drive the market growth
- 3.3 Market Restraints
- 3.3.1. Extortionate cost of conducting trials to hamper the growth of the industry
- 3.4 Market Opportunities
- 3.4.1. Increase in the development of new technologies create ample opportunities for the industry
- 3.5 Market Challenges
- 3.5.1. Shortage of skilled professionals to act as a challenge for the industry
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Phase
- 3.7.2 Market attractiveness analysis By Study Design
- 3.7.3 Market attractiveness analysis By Indication
- Chapter 4. Global Clinical Trials Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Clinical Trials Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Clinical Trials Market - Phase Analysis
- 5.1 Global Clinical Trials Market overview: By Phase
- 5.1.1 Global Clinical Trials Market share, By Phase, 2022 and 2030
- 5.2 Phase I
- 5.2.1 Global Clinical Trials Market by Phase I, 2023 - 2030 (USD Billion)
- 5.3 Phase II
- 5.3.1 Global Clinical Trials Market by Phase II, 2023 - 2030 (USD Billion)
- 5.4 Phase III
- 5.4.1 Global Clinical Trials Market by Phase III, 2023 - 2030 (USD Billion)
- 5.5 Phase IV
- 5.5.1 Global Clinical Trials Market by Phase IV, 2023 - 2030 (USD Billion)
- 5.1 Global Clinical Trials Market overview: By Phase
- Chapter 6. Global Clinical Trials Market - Study Design Analysis
- 6.1 Global Clinical Trials Market overview: By Study Design
- 6.1.1 Global Clinical Trials Market share, By Study Design, 2022 and 2030
- 6.2 Observational
- 6.2.1 Global Clinical Trials Market by Observational, 2023 - 2030 (USD Billion)
- 6.3 Interventional
- 6.3.1 Global Clinical Trials Market by Interventional, 2023 - 2030 (USD Billion)
- 6.4 Expanded Access
- 6.4.1 Global Clinical Trials Market by Expanded Access, 2023 - 2030 (USD Billion)
- 6.1 Global Clinical Trials Market overview: By Study Design
- Chapter 7. Global Clinical Trials Market - Indication Analysis
- 7.1 Global Clinical Trials Market overview: By Indication
- 7.1.1 Global Clinical Trials Market share, By Indication, 2022 and 2030
- 7.2 Gastrointestinal
- 7.2.1 Global Clinical Trials Market by Gastrointestinal, 2023 - 2030 (USD Billion)
- 7.3 Cardiovascular
- 7.3.1 Global Clinical Trials Market by Cardiovascular, 2023 - 2030 (USD Billion)
- 7.4 Autoimmune/Inflammation
- 7.4.1 Global Clinical Trials Market by Autoimmune/Inflammation, 2023 - 2030 (USD Billion)
- 7.5 Pain management
- 7.5.1 Global Clinical Trials Market by Pain management, 2023 - 2030 (USD Billion)
- 7.6 CNS condition
- 7.6.1 Global Clinical Trials Market by CNS condition, 2023 - 2030 (USD Billion)
- 7.7 Cancer
- 7.7.1 Global Clinical Trials Market by Cancer, 2023 - 2030 (USD Billion)
- 7.8 Mental disorders
- 7.8.1 Global Clinical Trials Market by Mental disorders, 2023 - 2030 (USD Billion)
- 7.9 Oncology
- 7.9.1 Global Clinical Trials Market by Oncology, 2023 - 2030 (USD Billion)
- 7.10 Diabetes
- 7.10.1 Global Clinical Trials Market by Diabetes, 2023 - 2030 (USD Billion)
- 7.11 Obesity
- 7.11.1 Global Clinical Trials Market by Obesity, 2023 - 2030 (USD Billion)
- 7.12 Others
- 7.12.1 Global Clinical Trials Market by Others, 2023 - 2030 (USD Billion)
- 7.1 Global Clinical Trials Market overview: By Indication
- Chapter 8. Clinical Trials Market - Regional Analysis
- 8.1 Global Clinical Trials Market Regional Overview
- 8.2 Global Clinical Trials Market Share, by Region, 2022 & 2030 (USD Billion)
- 8.3. North America
- 8.3.1 North America Clinical Trials Market, 2023 - 2030 (USD Billion)
- 8.3.1.1 North America Clinical Trials Market, by Country, 2023 - 2030 (USD Billion)
- 8.3.1 North America Clinical Trials Market, 2023 - 2030 (USD Billion)
- 8.4 North America Clinical Trials Market, by Phase, 2023 - 2030
- 8.4.1 North America Clinical Trials Market, by Phase, 2023 - 2030 (USD Billion)
- 8.5 North America Clinical Trials Market, by Study Design, 2023 - 2030
- 8.5.1 North America Clinical Trials Market, by Study Design, 2023 - 2030 (USD Billion)
- 8.6 North America Clinical Trials Market, by Indication, 2023 - 2030
- 8.6.1 North America Clinical Trials Market, by Indication, 2023 - 2030 (USD Billion)
- 8.4. Europe
- 8.4.2 Europe Clinical Trials Market, 2023 - 2030 (USD Billion)
- 8.4.2.1 Europe Clinical Trials Market, by Country, 2023 - 2030 (USD Billion)
- 8.4.2 Europe Clinical Trials Market, 2023 - 2030 (USD Billion)
- 8.4 Europe Clinical Trials Market, by Phase, 2023 - 2030
- 8.4.1 Europe Clinical Trials Market, by Phase, 2023 - 2030 (USD Billion)
- 8.5 Europe Clinical Trials Market, by Study Design, 2023 - 2030
- 8.5.1 Europe Clinical Trials Market, by Study Design, 2023 - 2030 (USD Billion)
- 8.6 Europe Clinical Trials Market, by Indication, 2023 - 2030
- 8.6.1 Europe Clinical Trials Market, by Indication, 2023 - 2030 (USD Billion)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Clinical Trials Market, 2023 - 2030 (USD Billion)
- 8.5.3.1 Asia Pacific Clinical Trials Market, by Country, 2023 - 2030 (USD Billion)
- 8.5.3 Asia Pacific Clinical Trials Market, 2023 - 2030 (USD Billion)
- 8.4 Asia Pacific Clinical Trials Market, by Phase, 2023 - 2030
- 8.4.1 Asia Pacific Clinical Trials Market, by Phase, 2023 - 2030 (USD Billion)
- 8.5 Asia Pacific Clinical Trials Market, by Study Design, 2023 - 2030
- 8.5.1 Asia Pacific Clinical Trials Market, by Study Design, 2023 - 2030 (USD Billion)
- 8.6 Asia Pacific Clinical Trials Market, by Indication, 2023 - 2030
- 8.6.1 Asia Pacific Clinical Trials Market, by Indication, 2023 - 2030 (USD Billion)
- 8.6. Latin America
- 8.6.4 Latin America Clinical Trials Market, 2023 - 2030 (USD Billion)
- 8.6.4.1 Latin America Clinical Trials Market, by Country, 2023 - 2030 (USD Billion)
- 8.6.4 Latin America Clinical Trials Market, 2023 - 2030 (USD Billion)
- 8.4 Latin America Clinical Trials Market, by Phase, 2023 - 2030
- 8.4.1 Latin America Clinical Trials Market, by Phase, 2023 - 2030 (USD Billion)
- 8.5 Latin America Clinical Trials Market, by Study Design, 2023 - 2030
- 8.5.1 Latin America Clinical Trials Market, by Study Design, 2023 - 2030 (USD Billion)
- 8.6 Latin America Clinical Trials Market, by Indication, 2023 - 2030
- 8.6.1 Latin America Clinical Trials Market, by Indication, 2023 - 2030 (USD Billion)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Clinical Trials Market, 2023 - 2030 (USD Billion)
- 8.7.5.1 The Middle-East and Africa Clinical Trials Market, by Country, 2023 - 2030 (USD Billion)
- 8.7.5 The Middle-East and Africa Clinical Trials Market, 2023 - 2030 (USD Billion)
- 8.4 The Middle-East and Africa Clinical Trials Market, by Phase, 2023 - 2030
- 8.4.1 The Middle-East and Africa Clinical Trials Market, by Phase, 2023 - 2030 (USD Billion)
- 8.5 The Middle-East and Africa Clinical Trials Market, by Study Design, 2023 - 2030
- 8.5.1 The Middle-East and Africa Clinical Trials Market, by Study Design, 2023 - 2030 (USD Billion)
- 8.6 The Middle-East and Africa Clinical Trials Market, by Indication, 2023 - 2030
- 8.6.1 The Middle-East and Africa Clinical Trials Market, by Indication, 2023 - 2030 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 IQVIA
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 PPD
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Covance
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Parexel International
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Syneos Health
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Charles River Laboratories
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 ICON plc
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Medpace
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 PRA Health Sciences
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 WuXi AppTec
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Chiltern International
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Celerion
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Envigo
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Eurofins Scientific
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Frontage Laboratories
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Laboratory Corporation of America Holdings (LabCorp)
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 Novotech Pty Ltd.
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Pharmaron
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 Pharmaceutical Product Development LLC (PPD)
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 QuintilesIMS (now IQVIA)
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Among Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 IQVIA
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Clinical Trials Market, 2023 - 2030 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Clinical Trials Market attractiveness, By Phase
- 6. Global Clinical Trials Market attractiveness, By Study Design
- 7. Global Clinical Trials Market attractiveness, By Indication
- 8. Global Clinical Trials Market share by Phase, 2023 and 2030 (USD Billion)
- 9. Global Clinical Trials Market by Phase I, 2023 - 2030 (USD Billion)
- 10. Global Clinical Trials Market by Phase II, 2023 - 2030 (USD Billion)
- 11. Global Clinical Trials Market by Phase III, 2023 - 2030 (USD Billion)
- 12. Global Clinical Trials Market by Phase IV, 2023 - 2030 (USD Billion)
- 13. Global Clinical Trials Market share by Study Design, 2023 and 2030 (USD Billion)
- 14. Global Clinical Trials Market by Observational, 2023 - 2030 (USD Billion)
- 15. Global Clinical Trials Market by Interventional, 2023 - 2030 (USD Billion)
- 16. Global Clinical Trials Market by Expanded Access, 2023 - 2030 (USD Billion)
- 17. Global Clinical Trials Market share by Indication, 2023 and 2030 (USD Billion)
- 18. Global Clinical Trials Market by Gastrointestinal, 2023 - 2030 (USD Billion)
- 19. Global Clinical Trials Market by Cardiovascular, 2023 - 2030 (USD Billion)
- 20. Global Clinical Trials Market by Autoimmune/Inflammation, 2023 - 2030 (USD Billion)
- 21. Global Clinical Trials Market by Pain management, 2023 - 2030 (USD Billion)
- 22. Global Clinical Trials Market by CNS condition, 2023 - 2030 (USD Billion)
- 23. Global Clinical Trials Market by Cancer, 2023 - 2030 (USD Billion)
- 24. Global Clinical Trials Market by Mental disorders, 2023 - 2030 (USD Billion)
- 25. Global Clinical Trials Market by Oncology, 2023 - 2030 (USD Billion)
- 26. Global Clinical Trials Market by Diabetes, 2023 - 2030 (USD Billion)
- 27. Global Clinical Trials Market by Obesity, 2023 - 2030 (USD Billion)
- 28. Global Clinical Trials Market by Others, 2023 - 2030 (USD Billion)
- 29. Global Clinical Trials Market share, by Region, 2023 and 2030
- 30. North America Clinical Trials Market, 2023 - 2030 (USD Billion)
- 31. Europe Clinical Trials Market, 2023 - 2030 (USD Billion)
- 32. Asia Pacific Clinical Trials Market, 2023 - 2030 (USD Billion)
- 33. Latin America Clinical Trials Market, 2023 - 2030 (USD Billion)
- 34. The Middle-East and Africa Clinical Trials Market, 2023 - 2030 (USD Billion)
Table Of Tables
- 1. Global Clinical Trials Market: Snapshot
- 2. Drivers of the Clinical Trials Market: impact analysis
- 3. North America Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 4. North America Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 5. North America Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 6. U.S. Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 7. U.S. Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 8. U.S. Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 9. Canada Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 10. Canada Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 11. Canada Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 12. Europe Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 13. Europe Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 14. Europe Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 15. Germany Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 16. Germany Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 17. Germany Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 18. France Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 19. France Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 20. France Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 21. U.K. Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 22. U.K. Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 23. U.K. Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 24. Italy Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 25. Italy Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 26. Italy Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 27. Spain Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 28. Spain Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 29. Spain Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 30. Rest of Europe Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 31. Rest of Europe Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 32. Rest of Europe Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 33. Asia Pacific Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 34. Asia Pacific Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 35. Asia Pacific Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 36. China Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 37. China Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 38. China Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 39. Japan Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 40. Japan Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 41. Japan Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 42. India Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 43. India Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 44. India Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 45. South Korea Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 46. South Korea Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 47. South Korea Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 48. South-East Asia Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 49. South-East Asia Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 50. South-East Asia Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 51. Rest of Asia Pacific Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 52. Rest of Asia Pacific Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 53. Rest of Asia Pacific Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 54. Latin America Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 55. Latin America Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 56. Latin America Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 57. Brazil Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 58. Brazil Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 59. Brazil Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 60. Mexico Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 61. Mexico Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 62. Mexico Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 63. Rest of Latin America Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 64. Rest of Latin America Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 65. Rest of Latin America Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 66. The Middle-East and Africa Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 67. The Middle-East and Africa Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 68. The Middle-East and Africa Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 69. GCC Countries Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 70. GCC Countries Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 71. GCC Countries Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 72. South Africa Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 73. South Africa Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 74. South Africa Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
- 75. Rest of Middle-East Africa Clinical Trials Market revenue, By Phase, 2023 - 2030 (USD Billion)
- 76. Rest of Middle-East Africa Clinical Trials Market revenue, By Study Design, 2023 - 2030 (USD Billion)
- 77. Rest of Middle-East Africa Clinical Trials Market revenue, By Indication, 2023 - 2030 (USD Billion)
Methodology
FrequentlyAsked Questions
Clinical trials are research experiments carried out in individuals aimed at testing a medical, behavioral, or surgical intervention. They are the key platform for researchers to find out if a new medication is safe and successful in humans, such as a new medicine, medical device, or diet. A clinical study is also used to assess whether new treatments are more successful and/or have fewer adverse side effects than traditional therapies.
The global clinical trials market is predicted to increase at a CAGR of 5.93% during the forecast period.
The global clinical trials market was worth around USD 53.92 billion in 2022 and is expected to reach USD 85.01 billion by 2030.
The global clinical trials market is being driven by several factors, including the increasing prevalence of chronic and infectious diseases, growing demand for personalized medicine, advancements in technology, rising investment by pharmaceutical and biotechnology companies, and favorable government initiatives to support clinical research and development.
North America held a notable share in the global clinical trials market in 2022 and is likely to grow the fastest during the forecast period. The growth of the clinical trials market in North America is due to the presence of a large number of pharmaceutical and biotech companies, favorable regulatory framework, increasing investment in R&D activities, rising prevalence of chronic diseases, and growing demand for personalized medicine. The use of advanced technologies and the availability of skilled professionals further fuel market growth.
Some of the major companies operating in the clinical trials market include IQVIA, PPD, Covance, Parexel International, Syneos Health, Charles River Laboratories, ICON plc, Medpace, PRA Health Sciences, WuXi AppTec, Chiltern International, Celerion, Envigo, Eurofins Scientific, Frontage Laboratories, Laboratory Corporation of America Holdings (LabCorp), Novotech Pty Ltd., Pharmaron, Pharmaceutical Product Development, LLC (PPD), and QuintilesIMS (now IQVIA) among others.
Choose License Type
List of Contents
Industry Perspective: OverviewKey Insights Growth FactorsRestraintsOpportunitiesChallengesImpact due to the outbreak of COVID-19SegmentationRecent Developments Market:Report ScopeRegional AnalysisCompetitive PlayersThe report segment of the global clinical trials market is as follows:RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed